Athyrium Capital Management, LP
CIK 1728001
13F portfolio (2024-Q3)
$9M
Positions
2
As reported on this filer's Form 13F for 2024-Q3, filed 2024-11-12. Long positions in SEC Section 13(f) securities; a lagged quarterly snapshot, filed up to 45 days after quarter-end. This filer has stopped filing 13F reports.
| 1 | BIOR | BIORA THERAPEUTICS INC |
| 2 | PBYI | PUMA BIOTECHNOLOGY INC |
Top holdings — weights and history with Pro
This 13F filer is outside the free plan's window — the 50 largest filers by portfolio value plus our curated roster of managers. It is in neither group. Unlock everything with Pro — $29.99/moSee it live on AAPL →